Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Lu, Cheng  [Clear All Filters]
Journal Article
Huang C, Li Y, Zhao W, Zhang A, Lu C, Wang Z, Liu L. α2δ1 may be a potential marker for tumor stem cell in laryngeal squamous cell carcinoma. Cancer Biomark. 2018.
Kong W, Zhang J, Lu C, Ding Y, Meng Y. Update of treatment for mucopolysaccharidosis type III (sanfilippo syndrome). Eur J Pharmacol. 2020:173562.
Liu X, Li B, Zhang Z, Wei Y, Xu Z, Qin S, Liu N, Zhao R, Peng J, Yang G, et al. Synthesis and Discovery Novel Anti-Cancer Stem Cells Compounds Derived from the Natural Triterpenoic Acids. J Med Chem. 2018.
Huang C, Wang Z, Zhang K, Dong Y, Zhang A, Lu C, Liu L. MicroRNA-107 inhibits proliferation and invasion of laryngeal squamous cell carcinoma cells by targeting CACNA2D1 in vitro. Anticancer Drugs. 2019.
Bi Q, Wang C, Cheng G, Chen N, Wei B, Liu X, Li L, Lu C, He J, Weng Y, et al. Microglia-derived PDGFB promotes neuronal potassium currents to suppress basal sympathetic tonicity and limit hypertension. Immunity. 2022.
Li X, Lu C, Fan D, Lu X, Xia Y, Zhao H, Xu H, Zhu Y, Li J, Liu H, et al. Human Umbilical Mesenchymal Stem Cells Display Therapeutic Potential in Rheumatoid Arthritis by Regulating Interactions Between Immunity and Gut Microbiota the Aryl Hydrocarbon Receptor. Front Cell Dev Biol. 2020;8:131.
Xue X, Wang X, Pang M, Yu L, Qian J, Li X, Tian M, Lu C, Xiao C, Liu Y. An exosomal strategy for targeting cancer-associated fibroblasts mediated tumors desmoplastic microenvironments. J Nanobiotechnology. 2024;22(1):196.